{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:21:05Z","timestamp":1790198465015,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejca.2013.08.009","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T17:15:16Z","timestamp":1378228516000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin"],"prefix":"10.1016","volume":"50","author":[{"given":"Irene","family":"Thomassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob H.A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette R.B.M.","family":"van Gestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes J.","family":"van de Wouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery E.P.P.","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H.J.T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.08.009_b0005","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/ijc.25596","article-title":"Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study","volume":"128","author":"Lemmens","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2013.08.009_b0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","article-title":"Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study","volume":"42","author":"Thomassen","year":"2013","journal-title":"Pancreas"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2013.08.009_b0015","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2013.08.009_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-5876-10-12","article-title":"Cancers of unknown primary origin: current perspectives and future therapeutic strategies","volume":"10","author":"Stella","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejca.2013.08.009_b0025","unstructured":"Verhoeven RH, de Hingh IH, Van de Wouw AJ, Lemmens VE. Incidence and survival of carcinoma of unknown primary: a population based study, in press."},{"key":"10.1016\/j.ejca.2013.08.009_b0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0959-8049(01)00378-1","article-title":"Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984\u20131992","volume":"38","author":"van de Wouw","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.08.009_b0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10147-008-0784-0","article-title":"Chemotherapy for metastatic disease: review from JCOG trials","volume":"13","author":"Boku","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0040","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0045","first-page":"256","article-title":"Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications","volume":"31","author":"Dovern","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jso.22017","article-title":"Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity","volume":"104","author":"Gill","year":"2011","journal-title":"J Surg Oncol"},{"issue":"Suppl. 6","key":"10.1016\/j.ejca.2013.08.009_b0055","doi-asserted-by":"crossref","first-page":"vi64","DOI":"10.1093\/annonc\/mdr389","article-title":"Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Fizazi","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ije\/22.3.369","article-title":"Completeness of cancer registration in Limburg, The Netherlands","volume":"22","author":"Schouten","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejca.2013.08.009_b0065","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2214\/AJR.12.9363","article-title":"Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know","volume":"200","author":"Kim","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejca.2013.08.009_b0070","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2214\/ajr.168.5.9129439","article-title":"Search for a primary lung neoplasm in patients with brain metastasis: is the chest radiograph sufficient?","volume":"168","author":"Latief","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejca.2013.08.009_b0075","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s11547-006-0112-6","article-title":"18F-FDG PET\/CT in the assessment of carcinoma of unknown primary origin","volume":"111","author":"Ambrosini","year":"2006","journal-title":"Radiol Med"},{"key":"10.1016\/j.ejca.2013.08.009_b0080","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/hed.21635","article-title":"Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET\/CT","volume":"33","author":"Keller","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2013.08.009_b0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.22410","article-title":"The role of 2-deoxy-2-[F-18]fluoro-d-glucose positron emission tomography in disseminated carcinoma of unknown primary site","volume":"109","author":"Seve","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.009_b0090","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2013.08.009_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000071198","article-title":"How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma","volume":"65","author":"Sevinc","year":"2003","journal-title":"Oncology"},{"issue":"Suppl. 10","key":"10.1016\/j.ejca.2013.08.009_b0100","doi-asserted-by":"crossref","first-page":"x271","DOI":"10.1093\/annonc\/mds357","article-title":"Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling","volume":"23","author":"Oien","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0105","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2002.04.019","article-title":"Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site","volume":"20","author":"Culine","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0110","first-page":"00040","article-title":"Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature","volume":"S0305\u20137372","author":"Petrakis","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2013.08.009_b0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.009_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/02841860510029554","article-title":"Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?","volume":"44","author":"Pentheroudakis","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/030089160108700201","article-title":"Peritoneal carcinomatosis from an unknown primary site. Management of 15 patients","volume":"87","author":"Sebbag","year":"2001","journal-title":"Tumori"},{"key":"10.1016\/j.ejca.2013.08.009_b0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2354.2008.00955.x","article-title":"Management of peritoneal carcinomatosis secondary to metastatic cancer of unknown primary in men","volume":"18","author":"Mugerwa","year":"2009","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.ejca.2013.08.009_b0135","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/COC.0b013e3182438c55","article-title":"Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin","volume":"36","author":"Klaver","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0150","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.009_b0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000338740","article-title":"Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosis","volume":"6","author":"de Mestier","year":"2012","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.ejca.2013.08.009_b0160","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913007739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913007739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T03:23:51Z","timestamp":1596425031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913007739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0959804913007739"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.08.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}